Physician profile

Christopher Mark Donald

General Practice (Dentist) · Daphne, AL

NPI 1942374582

$1,214.21

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$814.53
Food and Beverage$257.38
Entertainment$64.53
Gift$17.51

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Patterson Companies, INC. $869.50 2023-2024
Dentsply Sirona INC $266.94 2024 Cerec
Premier Dental Products Company $35.00 2019
Ultradent Products INC $17.51 2023 Opalescence
Voco America INC. $12.91 2022
Essential Dental Systems Incorporated $12.35 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher Mark Donald

$1,214.21

in general payments reported 2019-2025

Years
2019-2024
Top company
Patterson Companies, INC.

https://glasscript.com/doctor/314773/christopher-mark-donald

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.